HCA Healthcare, Inc. (NYSE:HCA) Shares Purchased by Intech Investment Management LLC

Intech Investment Management LLC increased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 63.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 276,269 shares of the company’s stock after purchasing an additional 106,986 shares during the quarter. HCA Healthcare accounts for approximately 2.5% of Intech Investment Management LLC’s investment portfolio, making the stock its 9th largest holding. Intech Investment Management LLC’s holdings in HCA Healthcare were worth $82,922,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of HCA. Whipplewood Advisors LLC acquired a new stake in shares of HCA Healthcare during the fourth quarter worth about $31,000. Tidemark LLC acquired a new position in HCA Healthcare in the fourth quarter valued at approximately $36,000. Legacy Investment Solutions LLC acquired a new position in HCA Healthcare in the third quarter valued at approximately $39,000. Activest Wealth Management lifted its holdings in HCA Healthcare by 1,250.0% in the fourth quarter. Activest Wealth Management now owns 135 shares of the company’s stock valued at $40,000 after acquiring an additional 125 shares during the period. Finally, Pinnacle Bancorp Inc. lifted its holdings in HCA Healthcare by 50.0% in the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after acquiring an additional 50 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $328.73 on Tuesday. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The business’s fifty day simple moving average is $319.64 and its 200-day simple moving average is $344.49. The firm has a market cap of $80.94 billion, a PE ratio of 14.96, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter last year, the business posted $5.90 EPS. Equities analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be issued a dividend of $0.72 per share. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 annualized dividend and a yield of 0.88%. HCA Healthcare’s dividend payout ratio is 13.11%.

Insiders Place Their Bets

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the company’s stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the sale, the senior vice president now owns 15,412 shares in the company, valued at $4,971,757.08. This represents a 38.22 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.60% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. Bank of America cut their price objective on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research report on Monday, January 27th. JPMorgan Chase & Co. restated a “neutral” rating and issued a $380.00 price objective on shares of HCA Healthcare in a research report on Tuesday, December 17th. Raymond James cut HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. Barclays dropped their price target on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a research report on Monday, January 27th. Finally, Truist Financial dropped their price target on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. One analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $385.67.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.